EradiKate ACNE TREATMENT
- Manufacturer
- Rare Beauty Brands Inc
- Effective date
- 2025-12-01
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 9
- Source
- full-release
- Hydrated at
- 2026-06-01 01:18:49
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
ACTIVE INGREDIENTS:
SULFUR, 10%
OTC - PURPOSE SECTION
PURPOSE
ACNE TREATMENT
INDICATIONS & USAGE SECTION
USES
- FOR THE TRETAMENT OF ACNE
- HELPS KEEP SKIN CLEAR OF NEW ACNE BLEMISHES
WARNINGS SECTION
WARNINGS
FOR EXTERNAL USE ONLY
OTC - WHEN USING SECTION
WHEN USING THIS PRODUCT
- USING OTHER TOPICAL ACNE MEDICATION AT THE SAME TIME OR IMMEDIATELY FOLLOWING THE USE OF THIS PRODUCT MAY INCREASE DRYNESS OR IRRITATION OF THE SKIN. IF THIS OCCURS, ONLY ONE MEDICATION SHOULD BE USED UNLESS DIRECTED BY A DOCTOR.
- AVOID CONTACT WITH EYES. IF EXCESSIVE SKIN IRRITATION DEVELOPS OR INCREASES, DISCONTINUE USE AND CONSULT A DOCTOR.
OTC - STOP USE SECTION
STOP USE AND ASK A DOCTOR IF SKIN IRRITATION OCCURS.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
KEEP OUT OF REACH OF CHILDREN. IF SWALLOWED, GET MEDICAL HELP OR CONTACT A POISON CONTROL CENTER RIGHT AWAY.
DOSAGE & ADMINISTRATION SECTION
DIRECTIONS
- CLEANSE SKIN THOROUGHLY BEFORE APPLYING. COVER THE AFFECTED AREA WITH A THIN LAYER 1 TO 3 TIMES A DAY. BECAUSE EXCESSIVE DRYING OF THE SKIN MAY OCCUR, START WITH 1 APPLICATION DAILY, THEN GRADUALLY INCREASE TO 2 OR 3 TIMES DAILY IF NEEDED OR AS DIRECTED BY A DOCTOR. IF BOTHERSOME DRYNESS OR PEELING OCCURS, REDUCE APPLICATION TO ONCE A DAY OR EVERY OTHER DAY.
OTHER SAFETY INFORMATION
OTHER INFORMATION
- DO NOT USE THIS PRODUCT IF YOU HAVE VERY SENSITIVE SKIN OR IF YOU ARE SENSITIVE TO SULFUR.
- YOU MAY REPORT A SERIOUS ADVERSE REACTION FROM USING THIS PRODUCT TO 1-800-981-KATE ON WEEKDAYS 9A.M.-5P.M. PACIFIC TIME.
INACTIVE INGREDIENT SECTION
INACTIVE INGREDIENT
ISOPROPYL ALCOHOL, WATER/AQUA/EAU, CAMPHOR, MAGNESIUM ALUMINUM SILICATE, SALICYLIC ACID, IRON OXIDES (CI 77489, CI 77491, CI 77492, CI 77499), ZINC OXIDE (CI 77947)
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed RxNorm Mappings#
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 6c13b22c-b3ba-4127-b768-0132dd5ab0d1 | Product name | 1 | 20230829 |
| dea2eded-d1e7-46bb-9a3d-f8dc20de6277 | Product name | 1 | 20190408 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72204-901-01 | EradiKate ACNE TREATMENT | 30 mL in 1 BOTTLE, GLASS | LIQUID | 30 | 9 | |
| 72204-901-02 | EradiKate ACNE TREATMENT | 1 in 1 BOX | LIQUID | 1 | 9 |
Products#
Every source-derived product name is available through these pages.
- EradiKate ACNE TREATMENT
- SULFUR
- ISOPROPYL ALCOHOL
- WATER
- CAMPHOR (NATURAL)
- MAGNESIUM ALUMINUM SILICATE
- SALICYLIC ACID
- FERROUS OXIDE
- FERRIC OXIDE RED
- FERRIC OXIDE YELLOW
- FERROSOFERRIC OXIDE
- ZINC OXIDE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 72204-901 | 72204-901-01, 72204-901-02 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ISOPROPYL ALCOHOL | ND2M416302 | IACT |
| WATER | 059QF0KO0R | IACT |
| CAMPHOR (NATURAL) | N20HL7Q941 | IACT |
| MAGNESIUM ALUMINUM SILICATE | 6M3P64V0NC | IACT |
| SALICYLIC ACID | O414PZ4LPZ | IACT |
| FERROUS OXIDE | G7036X8B5H | IACT |
| FERRIC OXIDE RED | 1K09F3G675 | IACT |
| FERRIC OXIDE YELLOW | EX438O2MRT | IACT |
| FERROSOFERRIC OXIDE | XM0M87F357 | IACT |
| ZINC OXIDE | SOI2LOH54Z | IACT |
| SULFUR | 70FD1KFU70 | ACTIB |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| EradiKate ACNE TREATMENT | SULFUR | Rare Beauty Brands Inc | 44ebacf3-52c1-4896-e063-6394a90ac447 | 2025-12-01 | Warnings | 72204-901-02 72204-901-01 72204-901 72204090101 72204090102 44eba48d-5fc8-38ea-e063-6394a90ad2e9 44ebacf3-52c1-4896-e063-6394a90ac447 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.

